Last 10.56 INR
Change Today -0.09 / -0.85%
Volume 18.0K
ORTL On Other Exchanges
Symbol
Exchange
Mumbai
As of 5:10 AM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

ortin laboratories ltd (ORTL) Snapshot

Open
10.50
Previous Close
10.65
Day High
11.00
Day Low
10.50
52 Week High
09/23/14 - 19.00
52 Week Low
03/26/14 - 9.28
Market Cap
178.9M
Average Volume 10 Days
21.9K
EPS TTM
0.70
Shares Outstanding
16.9M
EX-Date
09/24/13
P/E TM
15.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for ORTIN LABORATORIES LTD (ORTL)

Related News

No related news articles were found.

ortin laboratories ltd (ORTL) Related Businessweek News

No Related Businessweek News Found

ortin laboratories ltd (ORTL) Details

Ortin Laboratories Limited manufactures and sells drug intermediates and pharmaceuticals in India. The company offers a range of pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti diabetics, anti allergics, anti anginal and cardio vascular, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti biotics-quinolones, anti biotic-pencillins, antifungal, cephalosporins, and macrolides. The company’s formulations also include chemo therapeutics, antacids and anti ulcerants, anti spasmodic, calcium preparations, iron preparations, anti arthritic drugs, protein supplements, enzymes and vitamins, psychiatry, appetizers, gynaec, and anti retrovirals. In addition, it provides active pharmaceutical ingredients (APIs) comprising anti retro viral, anti diabetics, analgesics and antipyretics, anti biotic, antifungal, antacids and anti ulcerants, and anti malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company offers services in the areas of process development, process characterization, analytical research and development, assay development, and product characterization; and diagnostic services, including development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs. Ortin Laboratories Limited was founded in 1986 and is headquartered in Hyderabad, India.

Founded in 1986

ortin laboratories ltd (ORTL) Top Compensated Officers

Chairman, Managing Director and Compliance Of...
Total Annual Compensation: 1.5M
Joint Managing Director and Additional Direct...
Total Annual Compensation: 960.0K
Whole Time Director and Member of Audit Commi...
Total Annual Compensation: 1.5M
Whole-Time Director
Total Annual Compensation: 1.1M
Whole Time Director
Total Annual Compensation: 960.0K
Compensation as of Fiscal Year 2014.

ortin laboratories ltd (ORTL) Key Developments

Ortin Laboratories Ltd. Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2014

Ortin Laboratories Ltd. reported unaudited standalone earnings results for the second quarter and six months ended September 30, 2014. For the quarter, the company's net sales/income from operations was INR 109.159 million compared to INR 191.203 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 19.817 million compared to INR 16.576 million a year ago. Profit from ordinary activities before tax was INR 11.00 million compared to INR 8.164 million a year ago. Net profit was INR 7.448 million compared to INR 5.446 million a year ago. Basic and diluted earnings per share before and after extraordinary items was INR 0.44 compared to INR 0.32 a year ago. For the six months, the company's net sales/income from operations was INR 174.102 million compared to INR 332.475 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 32.463 million compared to INR 31.883 million a year ago. Profit from ordinary activities before tax was INR 16.015 million compared to INR 15.314 million a year ago. Net profit was INR 10.805 million compared to INR 10.22 million a year ago. Basic and diluted earnings per share before and after extraordinary items was INR 0.64 compared to INR 0.60 a year ago.

Ortin Laboratories Ltd., Board Meeting, Nov 14, 2014

Ortin Laboratories Ltd., Board Meeting, Nov 14, 2014. Agenda: To consider quarterly results.

Ortin Laboratories Ltd. Approves the Amendment to the Article of Association

Ortin Laboratories Ltd. announced that at its annual general meeting held on September 30, 2014, the shareholders approved the amendment of article of association of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ORTL:IN 10.56 INR -0.09

ORTL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ORTL.
View Industry Companies
 

Industry Analysis

ORTL

Industry Average

Valuation ORTL Industry Range
Price/Earnings 13.9x
Price/Sales 0.3x
Price/Book 0.8x
Price/Cash Flow 6.9x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORTIN LABORATORIES LTD, please visit www.ortinlabsindia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.